Abstract

This article reviews the management of diabetic ketoacidosis (DKA) in adults with a focus on the three basic principles of treatment: intravenous fluid therapy, intravenous insulin administration and potassium replacement. The recommendations are modelled on the national guidance for the management of DKA in children. We highlight the importance of being alert to signs of life-threatening complications of the condition such as cerebral oedema and adult respiratory distress syndrome (ARDS). We also discuss the use of near-patient testing of capillary beta-hydroxybutyrate (b-OHB) using a ketone meter as an aid to managing and preventing DKA.
[download-attachments container="div" style="list" dipslay_icon="1" display_count="1" display__size="0"]

References

1. British Society for Paediatric Endocrinology and Diabetes. BSPED consensus statement for the management of DKA. www.bsped.org.uk/ professional/guidelines/docs/BSPDDKAApr04.pdf.
2. Dunger DB, Sperling MA, Acerini CL et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 2004; 89: 188–94.
3. Umpierrez GE. Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care 2006; 29(12): 2755–7.
4. Henriksen OM, Roder ME, Prahl JB et al. Diabetic ketoacidosis in Denmark Incidence and mortality estimated from public health registries. Diabetes Res Clin Pract 2006 Sep 5; [Epub ahead of print].
5. Levetan CS, Passaro MD, Jablonski KA et al. Effects of physician specialty on ourcomes in DKA. Diabetes Care 1999; 22: 1790–5.
6. Edge JA, Hawkins MM, Winter DL et al. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child 2001; 85: 16–22.
7. Troy PJ, Clark RP, Kakarala SG, Burns J et al. Cerebral edema during treatment of diabetic ketoacidosis in an adult with new onset diabetes. Neurocrit Care 2005; 2(1): 55–8.
8. Glaser N, Barnett P, McCaslin I et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med 2001; 344: 264–9.
9. Edge JA, Jakes RW, Roy Y et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia 2006; 49: 2002–9.
10. Colloid versus crystalloid for fluid resuscitation in critically ill patients. Cochrane Systematic Review 2004 Oct 18; (4): CD000567.
11. Green SM, Rothrock SG, Ho JD et al. Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Ann Emerg Med 1998; 31: 41–8.
12. Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med 1986; 105(6): 836–40.
13. Tso EL, Barish RA. Magnesium:clinical considerations. J Emerg Med 1992; 10: 735–45.
14. Fisher JN, Kitabchi AE. A randomised study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 1983; 57: 177–80.
15. Wallace TM, Meeston NM, Gardner SG, Matthews DR. The hospital and home use of a 30-second hand-held blood ketone meter: guidelines for clinical practice. Diabet Med 2001 Aug; 18(8): 640–5.
16. Harris GD, Fiordalisi I. Physiologic management of diabetic ketoacidemia. A 5-year prospective pediatric experience in 231 episodes. Arch Pediatr Adolesc Med 1994; 148: 1046–52.
17. Kitabchi AE, Umpierrez GE, Murphy MB: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. In International Textbook of Diabetes Mellitus. 3rd ed. DeFronzo RA, Ferrannini E, Keen H and Zimmet P, Eds. John Wiley & Sons, Chichester, U.K., 2004, p. 1101–19.
18. Adrogue HJ, Wilson H, Boyd AE 3rd, et al: Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med 307: 1603–10, 1982.
19. Kitabchi AE, Guillermo E, Umpierrez GE et al: Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2006; 29: 2739–48,.
20. Rewers A, McFann K, Chase HP. Bedside monitoring of betahydroxybutyrate levels in the management of diabetic ketocidosis in children. Diabetes Technol Ther 2006 Dec; 8(6): 671–6.
21. M Vanelli, G Chiari and C Capuano. Cost effectiveness of the direct measurement of 3-beta-hydroxybutyrate in the management of diabetic ketoacidosis in children. Diabetes Care 2003; 26(3): 959.
22. Kitabchi AE. Hyperglycemic crises: improving prevention and management. Am Fam Physician. 2005 May 1; 71(9): 1659–60.
23. Fabietti PG, Canonico V, Federici , Sarti E, et al. Model based study on monitoring ketone bodies to improve safety in intensive insulin therapy. Int J Artif Organs 2006 Jun; 29(6): 596–601.
24. Naunheim R, Jang TJ, Banet G, Richmond A, McGill J. Point-of-care test identifies diabetic ketoacidosis at triage. Acad Emerg Med 2006 Jun; 13(6): 683–5. Epub 2006 May 11.
25. Harris S, Nq R, Syed H, Hillson R. Near patient blood ketone measurements and their utility in predicting diabetic ketoacidosis. Diabet Med 2005 Feb; 22(2): 221–4.